CNB Bank’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $393K | Hold |
2,575
| – | – | 0.17% | 108 |
|
|
2025
Q4 | $355K | Sell |
2,575
-499
| -16% | -$65.3K | 0.15% | 111 |
|
|
2025
Q3 | $394K | Sell |
3,074
-261
| -8% | -$31.8K | 0.16% | 111 |
|
|
2025
Q2 | $404K | Sell |
3,335
-1,026
| -24% | -$116K | 0.19% | 104 |
|
|
2025
Q1 | $486K | Sell |
4,361
-1,761
| -29% | -$187K | 0.25% | 93 |
|
|
2024
Q4 | $596K | Sell |
6,122
-973
| -14% | -$104K | 0.28% | 86 |
|
|
2024
Q3 | $816K | Sell |
7,095
-1,684
| -19% | -$191K | 0.38% | 75 |
|
|
2024
Q2 | $935K | Sell |
8,779
-6,281
| -42% | -$630K | 0.45% | 64 |
|
|
2024
Q1 | $1.46M | Buy |
15,060
+198
| +1% | +$20.3K | 0.71% | 38 |
|
|
2023
Q4 | $1.5M | Sell |
14,862
-647
| -4% | -$62.5K | 0.81% | 33 |
|
|
2023
Q3 | $1.58M | Sell |
15,509
-511
| -3% | -$51.9K | 0.93% | 27 |
|
|
2023
Q2 | $1.62M | Sell |
16,020
-688
| -4% | -$68.8K | 0.95% | 27 |
|
|
2023
Q1 | $1.54M | Buy |
16,708
+495
| +3% | +$43.2K | 0.94% | 31 |
|
|
2022
Q4 | $1.47M | Sell |
16,213
-43
| -0.3% | -$3.62K | 0.92% | 32 |
|
|
2022
Q3 | $1.24M | Buy |
16,256
+271
| +2% | +$22.5K | 0.84% | 32 |
|
|
2022
Q2 | $1.35M | Sell |
15,985
-1,267
| -7% | -$111K | 0.87% | 30 |
|
|
2022
Q1 | $1.51M | Buy |
17,252
+679
| +4% | +$58.8K | 0.85% | 32 |
|
|
2021
Q4 | $1.45M | Sell |
16,573
-77
| -0.5% | -$6.39K | 0.79% | 33 |
|
|
2021
Q3 | $1.36M | Buy |
16,650
+1,907
| +13% | +$172K | 0.82% | 32 |
|
|
2021
Q2 | $1.34M | Sell |
14,743
-27
| -0.2% | -$2.4K | 0.84% | 33 |
|
|
2021
Q1 | $1.26M | Buy |
14,770
+370
| +3% | +$33.2K | 0.87% | 32 |
|
|
2020
Q4 | $1.36M | Buy |
14,400
+1,174
| +9% | +$103K | 1.03% | 23 |
|
|
2020
Q3 | $1.15M | Sell |
13,226
-1,292
| -9% | -$112K | 0.97% | 26 |
|
|
2020
Q2 | $1.27M | Buy |
14,518
+744
| +5% | +$64.2K | 1.12% | 19 |
|
|
2020
Q1 | $1.14M | Buy |
13,774
+2,424
| +21% | +$216K | 1.22% | 17 |
|
|
2019
Q4 | $1.07M | Buy |
11,350
+1,327
| +13% | +$119K | 0.91% | 28 |
|
|
2019
Q3 | $871K | Buy |
10,023
+1,951
| +24% | +$175K | 0.81% | 33 |
|
|
2019
Q2 | $737K | Buy |
8,072
+326
| +4% | +$27.6K | 0.63% | 46 |
|
|
2019
Q1 | $667K | Buy |
7,746
+460
| +6% | +$36.9K | 0.34% | 55 |
|
|
2018
Q4 | $560K | Buy |
7,286
+1,087
| +18% | +$84.6K | 0.36% | 47 |
|
|
2018
Q3 | $479K | Buy |
6,199
+46
| +0.7% | +$3.4K | 0.27% | 66 |
|
|
2018
Q2 | $416K | Buy |
6,153
+110
| +2% | +$7.59K | 0.24% | 72 |
|
|
2018
Q1 | $438K | Buy |
6,043
+299
| +5% | +$22.8K | 0.26% | 66 |
|
|
2017
Q4 | $432K | Buy |
+5,744
| New | +$433K | 0.26% | 63 |
|
Other funds holding NVS
CNB Bank's NVS Position: Q1 2026 in Review
CNB Bank held its Novartis (NVS) position steady in Q1 2026 at 2,575 shares worth $393K. The position accounts for 0.17% of the portfolio, ranked #108.
CNB Bank first reported a position in NVS in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.62M in Q2 2023. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- CNB Bank held 2,575 shares of Novartis worth $393K as of Q1 2026.
- CNB Bank left its Novartis share count unchanged in Q1 2026.
- Novartis made up 0.17% of CNB Bank's portfolio in Q1 2026, its #108 holding.
- CNB Bank first reported a position in Novartis in Q4 2017 and has held it in 34 quarters since.
- CNB Bank's Novartis position peaked at $1.62M in Q2 2023.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on CNB Bank's 13F filing for Q1 2026, filed 6 May 2026.